Vimarsana
Biggest News Aggregation in the World

Evive Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evive Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evive Biotech Today - Breaking & Trending Today

Propulsion of Small Lymphocytic Lymphoma Clinical Trial - Vimarsana News

Propulsion of Small Lymphocytic Lymphoma Clinical Trial

The global Small Lymphocytic Lymphoma Treatment market has significantly grown over the past few years and is expected to register rapid growth. Revenue...

Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery - Vimarsana News

Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery

/PRNewswire/ -- Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions, and Evive Biotech, a global...

Cocaine-like price hike: China's new cancer drug is approved in the US but will cost 30 times more - Vimarsana News

Cocaine-like price hike: China's new cancer drug is approved in the US but will cost 30 times more

Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.

Source: scmp.com
FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia - Vimarsana News

FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia

The new colony-stimulating factor from China proved comparable to pegfilgrastim (Neulasta) in clinical testing.

Aurobindo Pharma: Aurobindo Unit Gets Usfda Nod For Ryzeneuta | Hyderabad News - Vimarsana News

Aurobindo Pharma: Aurobindo Unit Gets Usfda Nod For Ryzeneuta | Hyderabad News

Hyderabad: Pharma major Aurobindo Pharma on Wednesday said the US Food & Drug Administration (USFDA) has approved Ryzneuta (Efbemalenograstim alfa inj.